Kaiser Permanente does cover Zepbound for sleep apnea, but only under narrow conditions. The drug is non-formulary, so it requires prior authorization. Your plan has to include a benefit for weight loss medications, your obstructive sleep apnea has to be severe by Kaiser’s definition, and you have to work through a step-therapy sequence that can take nine months or longer before Zepbound is approved.
Kaiser’s Clinical Criteria for Sleep Apnea
Kaiser Permanente Northwest’s published criteria, revised in June 2025 and effective August 7, 2025, set a higher bar than the FDA label. Kaiser requires a diagnosis of severe obstructive sleep apnea, defined as an apnea-hypopnea index (AHI) of 30 or greater.1Kaiser Permanente. Zepbound Criteria – Northwest Region Members with moderate OSA (AHI between 15 and 29) do not qualify, even though the FDA approved Zepbound for moderate-to-severe OSA. Some other insurers, such as Health Net of California, use the lower AHI threshold of 15.2Health Net of California. Zepbound Coverage Policy
You also have to meet all of the following:
- BMI of 30 or higher, with current weight documented within the last 30 days.
- A sleep study performed within the past three years, and no more than 5% body weight lost since that study.
- Obstructive sleep apnea only. Central or complex apnea does not qualify.
- Age 18 or older.
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- Active participation in a diet and exercise program.
The sleep apnea indication also carries the same step-therapy requirements Kaiser uses for weight management.3Kaiser Permanente. Zepbound Clinical Review Criteria – Northwest Commercial
The Step Therapy You Have To Complete First
Kaiser treats Zepbound as a last-resort option. Approval runs through two stages.
In stage one, you must have tried and failed an adequate trial (three months) of at least two of these medications: phentermine, diethylpropion, topiramate, phentermine/topiramate (Qsymia), or naltrexone/bupropion (Contrave). A documented allergy, intolerance, or contraindication to all of them can substitute.
In stage two, you must have tried and failed a minimum six-month trial of semaglutide (Ozempic or Wegovy), followed by a bariatric medicine chart review justifying the switch to Zepbound. Again, a documented allergy or contraindication to semaglutide can satisfy this step.1Kaiser Permanente. Zepbound Criteria – Northwest Region
If approved, coverage lasts 12 months. To renew, you have to submit updated weight and BMI documentation and show that you have achieved and maintained at least 5% weight loss since starting the drug.3Kaiser Permanente. Zepbound Clinical Review Criteria – Northwest Commercial
Does Your Plan Actually Include the Benefit?
Clinical eligibility only matters if your plan covers weight loss drugs in the first place. Kaiser’s criteria document states that coverage exists “ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss,” and directs members to contact Pharmacy Services in their home region to confirm.1Kaiser Permanente. Zepbound Criteria – Northwest Region
Many Kaiser plans exclude weight loss drugs entirely. The Kaiser Foundation Health Plan of Washington’s 2026 formulary, for example, excludes “drugs for weight loss” from most plans, though members can request a coverage exception when the prescriber documents medical necessity.4Kaiser Permanente. Kaiser Washington Drug Formulary
Federal employees and postal workers enrolled in Kaiser’s FEHB and PSHB plans do have coverage for GLP-1 medications at 50% coinsurance of the plan allowance, subject to prior authorization.5Kaiser Permanente. Kaiser Permanente FEHB Weight Management Programs and GLP-1 Requirements One estimate puts the out-of-pocket cost for certain FEHB members at roughly $45 to $65 per month when the drug is covered.6SingleCare. Does Kaiser Cover Zepbound
Medicare members are a different story. Kaiser’s Northwest criteria state they do not apply to Medicare Part D patients, and under federal law Part D plans have been prohibited from covering drugs prescribed for weight loss.1Kaiser Permanente. Zepbound Criteria – Northwest Region A separate federal demonstration, the Medicare GLP-1 Bridge Program, is scheduled to run from July 1, 2026 through December 31, 2027, offering certain weight-loss drugs including Zepbound (KwikPen) at a fixed $50 monthly copayment. Part D plans are not required to participate.7Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 2026
The detailed criteria above come from Kaiser’s Northwest region. Kaiser notes that policies vary by region, so confirm the exact rules with Pharmacy Services in your home region before you start the process.
If Kaiser Denies Your Request
You have 60 days from the denial notice to file a redetermination request with Kaiser, by mail, fax, or online at kp.org. You can attach a supporting statement from your prescriber and any relevant medical records. If waiting could seriously harm your health, call 1-866-206-2973 to request an expedited appeal; Kaiser must respond within 72 hours when your prescriber confirms the risk.8Kaiser Permanente. Medicare Part D Redetermination Request Form
A peer-to-peer review, where your prescribing doctor speaks directly with Kaiser’s medical director, can sometimes resolve a denial faster than a written appeal. After internal appeals are exhausted, members with fully insured plans may be eligible for an external review by an independent third party, which in many states produces a binding decision.
One angle worth considering: because Zepbound now has an FDA-approved indication for sleep apnea, members whose plans exclude weight loss drugs may have better luck framing the request under the sleep apnea indication rather than weight management. An appeal letter should cite the specific AHI diagnosis, the FDA approval for OSA, and clinical evidence of the drug’s efficacy for sleep apnea.
What Zepbound Costs if Kaiser Won’t Pay
Eli Lilly runs several patient programs. If you have commercial insurance that covers Zepbound, a manufacturer savings card can bring the cost down to as little as $25 per month. If you have commercial insurance that does not cover it, the savings card price is $499 per month. Uninsured or cash-pay patients can buy through LillyDirect or retail pharmacies starting at $299 per month for the 2.5 mg dose and $449 per month for maintenance doses of 7.5 mg through 15 mg, provided refills come within 45 days of the previous fill.9Eli Lilly. Zepbound Coverage and Savings for Healthcare Providers These manufacturer programs exclude patients enrolled in government-funded healthcare such as Medicare, Medicaid, VA, or TRICARE.